Heat shock protein 70 neutralization exerts potent antitumor effects in animal models of colon cancer and melanoma

Elise Schmitt, Loic Maingret, Pierre Emmanuel Puig, Anne Laure Rerole, François Ghiringhelli, Arlette Hammann, Eric Solary, Guido Kroemer, Carmen Garrido

    Research output: Contribution to journalArticlepeer-review

    130 Citations (Scopus)

    Abstract

    When overexpressed, the stress protein heat shock protein 70 (HSP70) increases the oncogenic potential of cancer cells in rodent models. HSP70 also prevents apoptosis, thereby increasing the survival of cells exposed to a wide range of otherwise lethal stimuli. These protective functions of HSP70 involve its interaction with and neutralization of the adaptor molecule apoptotic protease activation factor-1, implicated in caspase activation, and the flavoprotein apoptosis-inducing factor (AIF), involved in caspase-independent cell death. We have shown previously that a peptide containing the AIF sequence involved in its interaction with HSP70 (ADD70, amino acids 150-228) binds to and neutralizes HSP70 in the cytosol, thereby sensitizing cancer cells to apoptosis induced by a variety of death stimuli. Here, we show that expression of ADD70 in tumor cells decreases their tumorigenicity in syngeneic animals without affecting their growth in immunodeficient animals. ADD70 antitumorigenic effects are associated with an increase in tumor-infiltrating cytotoxic CD8+ T cells. In addition, ADD70 sensitizes rat colon cancer cells (PROb) and mouse melanoma cells (B16F10) to the chemotherapeutic agent cisplatin. ADD70 also shows an additive effect with HSP90 inhibition by 17-allylamino-17-demethoxygeldanamycin in vitro. Altogether, these data indicate the potential interest of targeting the HSP70 interaction with AIF for cancer therapy.

    Original languageEnglish
    Pages (from-to)4191-4197
    Number of pages7
    JournalCancer Research
    Volume66
    Issue number8
    DOIs
    Publication statusPublished - 15 Apr 2006

    Cite this